Feline aminopeptidase N (fAPN) is a major cell surface receptor for feline infectious peritonitis virus (FIPV), transmissible gastroenteritis virus (TGEV), human coronavirus 229E (HCV 229E) and canine coronavirus (CCV). By using chimeric molecules assembled from porcine, human and feline APN we have analysed the determinants involved in the coronavirus receptor function of fAPN. Our results show that amino acids 670-840 of fAPN are critically involved in its FIPV and TGEV receptor function whereas amino acids 135-297 are essential for the HCV 229E receptor function. We also demonstrate that a chimeric molecule assembled from human and porcine APN is able to act as a receptor for FIPV. This is surprising as neither human nor porcine APN by themselves mediate FIPV infection. These results suggest that different determinants in the APN protein are involved in mediating the coronavirus receptor function.
The Coronaviridae are enveloped viruses with a large nonsegmented RNA genome of positive polarity. On the basis of serological and genetic data they are separated into three different groups (Siddell, 1995) . Some members of group 1 [i.e. transmissible gastroenteritis virus (TGEV), feline infectious peritonitis virus (FIPV) and human coronavirus (HCV) 229E] have been demonstrated to utilize aminopeptidase N (APN) as cell surface receptor (Delmas et al., 1992 ; Yeager et al., 1992 ; Tresnan et al., 1996) . APN is a type II glycoprotein, belongs to the family of membrane-bound metalloproteases (Olsen et al., 1988) and is expressed in a variety of tissues (Delmas et al., 1994) .
Although human APN (hAPN) and porcine APN (pAPN) have a sequence similarity of 78 % at the amino acid level,
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Research Institute, Ayr KA6 5HL, UK. Fax j44 1292 674003. e-mail kolba!main.hri.sari.ac.uk hAPN only mediates the infection of HCV 229E whereas pAPN only mediates TGEV infection. In contrast, feline APN (fAPN) does not display this species specificity in that it serves as a receptor not only for FIPV but also for TGEV, HCV 229E and canine coronavirus (CCV) (Tresnan et al., 1996) . Consequently, cats can be infected with all of these viruses, although only infection with FIPV (or the feline enteric coronavirus variant, FECV) results in an overt disease (Barlough et al., 1984 (Barlough et al., , 1985 . FIPV infection, however, can only be mediated by fAPN but not by porcine or human APN (Delmas et al., 1993 ; Kolb et al., 1997) . Consequently, the feline cell lines CRFK and (Ringold et al., 1975) , Felis catus whole fetus cells (FCWF ; Jacobse-Geels & Horzinek, 1983) and MRC5 human embryonic lung fibroblasts (all cultivated as described previously ; Kolb et al., 1997) were infected with FIPV (strain 79-1146, propagated on FCWF cells) at an m.o.i. of 5 and labelled metabolically with [
35 S]methionine 6-9 h post-infection. Cytoplasmic extracts of the infected cells were precipitated with an FIPV-specific antiserum (de Groot et al., 1987) . The cellular lysates and the precipitated proteins were separated on a 15 % SDS-polyacrylamide gel and visualized by autoradiography. The molecular masses of the 14 C-labelled molecular mass marker proteins (Amersham) and the positions of the FIPV-specific structural proteins (surface glycoprotein, S ; nucleocapsid protein, N ; membrane protein, M) are indicated. The TGEV nucleocapsid (N) protein was detected by using the monoclonal antibody 3C/E4 (Sanchez et al., 1990) . The molecular masses of the marker proteins (Pharmacia) and the position of the TGEV nucleocapsid protein are indicated.
FCWF, which express fAPN (Kolb et al., 1997 ; Tresnan et al., 1996) , are susceptible to FIPV infection as evidenced by the precipitation of metabolically labelled FIPV structural proteins from cytoplasmic extracts of infected cells with an FIPVspecific antiserum (Fig. 1) . In contrast, the murine epithelial cell line GR, which was used as a negative control in this experiment, cannot be infected with FIPV. Similar to the negative control cell line, the human embryonic lung fibroblast cell line MRC5 and the porcine cell line ST, which express human (A. F. Kolb, unpublished) and porcine APN (Delmas et al., 1992) , respectively, are not susceptible to FIPV infection (Fig. 1) .
We have recently isolated an fAPN cDNA from CRFK cells (Kolb et al., 1997) . Expression of this fAPN cDNA in 293 human embryonic kidney (293 HEK) cells (which are nonpermissive to group 1 coronavirus infection) was able to mediate the infection of FIPV, HCV 229E and TGEV (Kolb et al., 1997) . The CRFK fAPN cDNA is thus functionally identical to the fAPN cDNA isolated from FCWF cells (Tresnan et al., 1996) . In order to identify the amino acid sequences within the fAPN protein which are critical for the FIPV receptor function we generated several chimeric APN genes and expressed the corresponding proteins in 293 HEK cells. As in the hAPN protein (Kolb et al., 1996) , the amino acid sequences required for the HCV 229E receptor function of fAPN are located within the amino-terminal part of the fAPN protein (amino acids 135-297 ; Kolb et al., 1997) . HCV 229E thus appears to be distinct from TGEV and CCV, which interact with amino acid sequences within the carboxy-terminal part of porcine and canine APN, respectively (Delmas et al, 1994 ; Benbacer et al., 1997) . As FIPV, TGEV and CCV are very closely related genetically and serologically (Horzinek et al., 1982 ; Sanchez et al., 1990) we anticipated that the determinants involved in FIPV reception would also be located in the carboxy-terminal part of fAPN. To test this hypothesis we generated the chimera AP33, which contains the fAPN amino acids 670-840 grafted onto an hAPN backbone thereby replacing the corresponding hAPN amino acids (Fig. 2 a) . To construct AP33 a 918 bp PCR product was amplified from the fAPN cDNA by using primers 32 (5h TTCAACCTGGCCAGTGCCCA 3h) and TAG (5h GGATCGATACTATTTGCTGTTTTTCTGTGAACCA 3h (Kolb et al., 1996) previously digested with the same enzymes. Human 293 HEK cells were transfected as described previously (Kolb et al., 1996) with chimera AP33 and the expression vector pBK-CMV-hAPN directing the synthesis of the unmodified hAPN. The transfection efficiencies were controlled by Southern blot analysis of the transfected DNAs (data not shown). Twenty-four hours post-transfection the cells were infected with FIPV at an m.o.i. of 5. De novo synthesized, metabolically labelled FIPV structural proteins were precipitated from cytoplasmic extracts 9 h post-infection and separated on a 15 % SDS-polyacrylamide gel. As shown in Fig. 2 (b) AP33 conferred susceptibility to FIPV infection, whereas pBKhAPN did not. This indicates that the determinants of the fAPN protein which are essential for its FIPV receptor function are located within amino acids 670-840. 293 HEK cells transiently transfected with chimera AP33 were also susceptible to TGEV infection (Fig. 2 c) whereas cells transfected with the expression vector pBK-CMV-hAPN were not (Fig.  2 c) . This indicates that the fAPN amino acids 670-840 also carry the determinants required for the TGEV receptor function of fAPN. These results additionally suggest that TGEV and FIPV interact with similar or identical determinants within the fAPN receptor protein.
Feline APN serves as a receptor for FIPV, TGEV and HCV 229E (Tresnan et al., 1996) , whereas porcine and human APN act species-specifically in only mediating the infection of TGEV and HCV 229E, respectively (Delmas et al., 1994 ; Kolb et al., 1996) . Chimeric molecules containing fragments of porcine and human APN, however, can serve as receptors for both TGEV and HCV 229E and thus function similar to fAPN. This has been demonstrated for the chimeras AP24 (Delmas et al., 1994 ; Kolb et al., 1996) and AP32 (A. F. Kolb, unpublished data). These chimeras were therefore analysed for their ability to mediate infection of FIPV (Fig. 3 a) . As a positive control, 293 HEK cells were transfected with the vector pBK-CMV-fAPN (an expression vector carrying the fAPN cDNA ; Kolb et al., 1997) . Chimera AP30, which is a functional receptor for TGEV but not for HCV 229E (Kolb et al., 1996) , was used as a negative control (Fig. 3 a) . As expected, all of the transfected constructs rendered the cells susceptible to TGEV infection (data not shown). However, only chimera AP32, which carries hAPN amino acids 260-353 grafted onto a pAPN backbone, could act as a receptor for FIPV (Fig. 3 b) . AP32 thus mediates infection not only of HCV 229E and TGEV but also of FIPV and thus functions similar to fAPN. As neither human nor porcine APN by itself confer susceptibility to FIPV (Delmas et al., 1993 ; Kolb et al., 1997) , the hAPN amino acids 260-353 have to cooperate with sequences in the pAPN backbone of AP32 to bring about the FIPV receptor function. These results suggest that two discontinuous regions (i.e. hAPN amino acids 260-353 in AP32 and amino acids 670-840 in fAPN) are involved in the FIPV-APN interaction.
These findings can be explained in two ways. Either FIPV interacts with two different alternative determinants when infecting cells via AP32 and AP33 or the two amino acid regions (260-353 and 670-840) are part of a single epitope which mediates the coronavirus infection via APN and in which different residues contribute to the virus-receptor interaction. Three lines of evidence suggest that the latter explanation is correct. First, the hAPN 260-353 region alone is not sufficient to mediate FIPV infection as neither hAPN nor the chimera AP24, which both contain this amino acid segment, confer susceptibility to FIPV (Fig. 3 b) . Secondly, the amino acid sequence of the hAPN 260-353 region does not have any apparent homologies to the pAPN 717-814 or the fAPN 670-840 domain so that the two domains are unlikely to function as alternative virus-interaction sites. A computer analysis using the EMBL Predict Protein program (Rost, 1996) indicates that the carboxy-terminal part of APN in which the pAPN 717-814 and fAPN 670-840 domains are located consists of a row of α-helices, whereas the hAPN 260-353 region encompasses an alternating sequence of α-helices and β-sheets. Thirdly and most importantly, an observation similar to the data presented in Fig. 3 was made with a chimera in which hAPN amino acids 643-841 were replaced by the corresponding region of bovine APN (Benbacer et al., 1997) . The chimeric protein was found to confer susceptibility to TGEV A. Hegyi and A. F. Kolb A. Hegyi and A. F. Kolb infection although neither human nor bovine APN are functional receptors for TGEV. The authors speculated that a determinant different from the previously mapped TGEVbinding site (pAPN amino acids 643-841) may be involved in the coronavirus-APN interaction. The data presented here support this conclusion and point to the amino-terminally located segment previously identified as the HCV 229E-binding site as a potential co-determinant. Additionally, the findings of Benbacer et al. and the data presented here suggest that both TGEV and FIPV (and possibly all group 1 coronaviruses) interact with discontinuous amino acid segments of the APN protein.
In conclusion, we have shown, first, that the fAPN region critically involved in the FIPV receptor function is located within the carboxy-terminal part of the protein (amino acids 670-840). Secondly, we have demonstrated that the determinants required for the TGEV receptor function are also located within this amino acid fragment. The close genetic and serological relationships between FIPV, CCV and TGEV are thus also mirrored at the level of the virus-receptor interaction. Thirdly, we have shown that it is possible to assemble a functional FIPV receptor from two APN molecules which by themselves do not mediate FIPV infection. The inability of AP24 to confer susceptibility to FIPV infection, however, indicates that not every chimeric APN molecule which serves as a receptor for TGEV and HCV 229E automatically acts as an FIPV receptor. These results imply that at least two discontinuous sequences within the APN molecule are involved in the coronavirus receptor function. The regions previously defined as being essential for the TGEV (Delmas et al., 1994) and HCV 229E receptor function (Kolb et al., 1996) most probably contain two of these determinants. In the absence of an APN crystal structure it is difficult to predict how these different determinants contribute to the biochemical interaction of APN with the coronavirus surface glycoproteins. However, we do believe that the data presented here may lead to a better understanding of the coronavirus-APN interaction and may, in the long term, add to the information needed for the development of a rational intervention strategy.
